Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Open accessThe DOI matches its Crossref record; 235 of the 237 references it cites were found in a registry or an index.
Abstract
NADPH oxidases are a family of enzymes that generate reactive oxygen species (ROS). The NOX1 (NADPH oxidase 1) and NOX2 oxidases are the major sources of ROS in the artery wall in conditions such as hypertension, hypercholesterolaemia, diabetes and ageing, and so they are important contributors to the oxidative stress, endothelial dysfunction and vascular inflammation that underlies arterial remodelling and atherogenesis. In this Review, we advance the concept that compared to the use of conventional antioxidants, inhibiting NOX1 and NOX2 oxidases is a superior approach for combating oxidative stress. We briefly describe some common and emerging putative NADPH oxidase inhibitors. In addition, we highlight the crucial role of the NADPH oxidase regulatory subunit, p47phox, in the activity of vascular NOX1 and NOX2 oxidases, and suggest how a better understanding of its specific molecular interactions may enable the development of novel isoform-selective drugs to prevent or treat cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The current knowledge about NOX enzymes in the cardiovascular system indicates that NOX2 is usually the main player in the development of pathological conditions and increased NOX2 activity is linked to vascular disease (142, 252, 478).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
The cited source says what the claim attributes to it.
In the citing paper
“In the human vasculature, the most relevant isoforms appear to be NOX1, NOX2, NOX4, and NOX5 (252, 253, 555).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
In the citing paper
“NADPH oxidase, a multiunit enzyme particularly enriched in cerebral blood vessels (Miller et al., 2005), has emerges as an important source in vascular oxidative stress in aging, hypertension, hyperlipidemia and diabetes (Faraci, 2011), and inhibition or genetic inactivation of this enzyme has been shown to ameliorate the vascular dysfunction (Drummond et al., 2011).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Drummond et al., 2011
In the citing paper
“NOXs are multiprotein enzyme complexes that catalyze the electron transfer to molecular oxygen to form ROS, more commonly superoxide, but also hydrogen peroxide (79, 252, 383, 546, 912).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
In the citing paper
“The current knowledge about NOX enzymes in the cardiovascular system indicates that NOX2 is usually the main player in the development of pathological conditions and increased NOX2 activity is linked to vascular disease (142, 252, 478).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–235 of 235
Witting, P. K., Upston, J. M., & Stocker, R. (1997) · Biochemistry · doi:10.1021/bi962493j · Cited by 66 · cited 1×
“Such a situation would not only lead to rapid depletion of the reduced (active) form of the antioxidant but may also cause accumulation of the oxidized form of the parent molecule, which in some instances (including for the vitamin E radical) may exert its own pro-oxidant and pro-atherogenic effect”
BackgroundRole of NOX2 in the regulation of afferent arteriole responsiveness
Carlström, M., Lai, E. Y., Ma, Z., Patzak, A., Brown, R. D., & Persson, A. E. G. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90718.2008 · Cited by 65
Wadham, C., & Mangoni, A. A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902785172 · Cited by 63 · cited 1×
“, as well as dimethylarginine dimethylaminohydrolase, which metabolizes the endogenous inhibitor of eNOS — asymmetric dimethylarginin”
BackgroundSolution Structure of the Tandem Src Homology 3 Domains of p47 in an Autoinhibited Form
Yuzawa, S., Ogura, K., Horiuchi, M., Suzuki, N. N., Fujioka, Y., Kataoka, M., Sumimoto, H., & Inagaki, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401457200 · Cited by 62 · cited 1×
“This closed configuration of p47phox is largely due to intramolecular interactions between its polybasic autoinhibitory region (AIR) and bis-SH3 domai”
BackgroundTowbin, A. J., & Chaves, I. (2010) · Pediatric Radiology · doi:10.1007/s00247-009-1503-3 · Cited by 61
Polyunsaturated fatty acids modulate NOX 4 anion superoxide production in human fibroblasts
Rossary, A., Arab, K., & Steghens, J.-P. (2007) · Biochemical Journal · doi:10.1042/bj20061009 · Cited by 60
Mechanism for phosphorylation-induced activation of the phagocyte NADPH oxidase protein p47phox
吾郷, 哲. (1999) · Institutional Repositories DataBase (IRDB) · doi:10.11501/3166670 · Cited by 59
Fan, C., Katsuyama, M., Nishinaka, T., & Yabe-Nishimura, C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.021 · Cited by 57
Jaulmes, A., Sansilvestri, P., Rolland-Valognes, G., Bernhardt, F., Gaertner, R., Lockhart, B. P., Cordi, A. A., Wierzbicki, M., Rupin, A., & Verbeuren, T. J. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.05.018 · Cited by 56 · cited 1×
“Furthermore, S17834 suppressed TNF-induced leukocyte adhesion, reduced expression of plasminogen activator inhibitor 1, augmented NO production in endothelial monolayers and displayed atheroprotective properties when it was administered chronically to ApoE- or LDL receptor-deficient mic”
BackgroundFuchs, A., Dagher, M., Fauré, J., & Vignais, P. V. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(96)00020-1 · Cited by 55
Small-Molecule Inhibitors of NADPH Oxidase 4
Borbély, G., Szabadkai, I., Horváth, Z., Markó, P., Varga, Z., Breza, N., Baska, F., Vántus, T., Huszár, M., Geiszt, M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1004368 · Cited by 53
Nobuhisa, I., Takeya, R., Ogura, K., Ueno, N., Kohda, D., Inagaki, F., & Sumimoto, H. (2006) · Biochemical Journal · doi:10.1042/bj20051899 · Cited by 52 · cited 1×
“As is common for many SH3–PRR interactions, the affinity and specificity of the p22phox PRR for the p47phox bis-SH3 domain are enhanced by a series of amino acids that are located just proximal to the PRR of p22phox (amino acids 161–164”
BackgroundTsai, M.-H., & Jiang, M. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-67 · Cited by 51 · cited 1×
“and limited phenylephrine-induced contractions in rat tail arterie”
BackgroundChu, X., Filali, M. S., Stanić, B., Takapoo, M., Sheehan, A. L., Bhalla, R. C., Lamb, F. S., & Miller, F. J. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.217604 · Cited by 51
Weaver, M., Liu, J., Pimentel, D., Reddy, D. J., Harding, P., Peterson, E. L., & Pagano, P. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00690.2005 · Cited by 50 · cited 1×
“An alternative strategy involving the adenoviral-mediated expression of either Nox2ds or a dominant negative p67phox construct in adventitial fibroblasts of the rat carotid artery in vivo reduced angioplasty-induced ROS production and neointimal proliferatio”
Backgroundp47 Molecular Activation for Assembly of the Neutrophil NADPH Oxidase Complex
Marcoux, J., Man, P., Petit-Haertlein, I., Vivès, C., Forest, E., & Fieschi, F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139824 · Cited by 49 · cited 1×
“, and also between its bis-SH3 domain and PX domain”
BackgroundGordillo, G., Fang, H., Park, H., & Roy, S. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2917 · Cited by 49
Oelze, M., Warnholtz, A., Faulhaber, J., Wenzel, P., Kleschyov, A. L., Coldewey, M., Hink, U., Pongs, O., Fleming, I., Wassmann, S., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000231511.26860.50 · Cited by 48
Hata, K., Takeshige, K., & Sumimoto, H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7807 · Cited by 45
Mizuki, K., Takeya, R., Kuribayashi, F., Nobuhisa, I., Kohda, D., Nunoi, H., Takeshige, K., & Sumimoto, H. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.10.012 · Cited by 45 · cited 1×
“Additional contacts with the SH3 domain of p67phox are made by a domain on p47phox that lies distal to the PRR on its C terminus (amino acids 368–390), and these contacts are important for increasing the affinity of the protein–protein interaction ( K A ∼20 nM) and for conferring binding partner specificit”
BackgroundRegulation of Endothelial Cell Tetrahydrobiopterin
Harrison, D. G., Chen, W., Dikalov, S., & Li, L. (2010) · Advances in pharmacology · doi:10.1016/b978-0-12-385061-4.00005-2 · Cited by 42
Wang, P., Tang, F., Li, R., Zhang, H., Chen, S., Liu, P., & Huang, H. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.01.016 · Cited by 41
Basset, O., Deffert, C., Foti, M., Bedard, K., Jaquet, V., Ogier-Denis, E., & Krause, K.-H. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2584 · Cited by 37
Witting, P. K., Willhite, C. A., Davies, M. J., & Stocker, R. (1999) · Chemical Research in Toxicology · doi:10.1021/tx9900472 · Cited by 32 · cited 1×
“Such a situation would not only lead to rapid depletion of the reduced (active) form of the antioxidant but may also cause accumulation of the oxidized form of the parent molecule, which in some instances (including for the vitamin E radical) may exert its own pro-oxidant and pro-atherogenic effect”
BackgroundSimons, J. M., Hart, L. A. '., van Dijk, H., Fischer, F., Silva, K. T. D. D., & Labadie, R. P. (1989) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(89)90064-0 · Cited by 31
Azenabor, A. A., Yang, S., Job, G., & Adedokun, O. O. (2004) · Medical Microbiology and Immunology · doi:10.1007/s00430-004-0223-4 · Cited by 30
Characterization of peptide diffusion into electropermeabilized neutrophils
DeLeo, F. R., Jutila, M. A., & Quinn, M. T. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00144-5 · Cited by 28 · cited 1×
“Short synthetic peptides spanning any one of the three p47phox-interacting domains on the NOX2 subunit acted as competitive inhibitors of NADPH oxidase activation in both cell-free systems and in electropermeabilized neutrophil”
MethodPark, M., Imajoh‐Ohmi, S., Nunoi, H., & Kanegasaki, S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6672 · Cited by 21 · cited 1×
“Short synthetic peptides spanning any one of the three p47phox-interacting domains on the NOX2 subunit acted as competitive inhibitors of NADPH oxidase activation in both cell-free systems and in electropermeabilized neutrophil”
MethodSH3 domain-mediated interactions involving the phox components of the NADPH oxidase
Wilson, L., Butcher, C., Finan, P. M., & Kellie, S. (1997) · Inflammation Research · doi:10.1007/s000110050185 · Cited by 19
Gatley, S. J., & Sherratt, H. S. A. (1976) · Biochemical Journal · doi:10.1042/bj1580317 · Cited by 16
Studies in vitro on the flavinylation of 6‐hydroxy‐ d ‐nicotine oxidase
Brandsch, R., & Bichler, V. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09969.x · Cited by 13
The C-terminal SH3 Domain of p67phoxBinds its Natural Ligand in a Reverse Orientation
Finan, P. M., Koga, H., Zvelebil, M., Waterfield, M. D., & Kellie, S. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0450 · Cited by 11
Nox is playing with a full deck in vascular smooth muscle
Lassegue, B. P., & Griendling, K. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.04.024 · Cited by 10
Self-citationWatanabe, Y., Tsuboi, H., Koyama, M., Kubo, M., Carpio, C. A. D., Brocławik, E., Ichiishi, E., Kohno, M., & Miyamoto, A. (2006) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2006.04.004 · Cited by 6 · cited 1×
“A key interaction in the assembly of the active NADPH oxidase complex occurs between the p47phox bis-SH3 domain — which is exposed following phosphorylation of the AIR — and a PRR present on the carboxy terminal of p22phox (amino acids 151–160”
BackgroundAbstract 1205: Role for Nox1 NADPH Oxidase in Atherosclerosis
Sheehan, A. L., Takapoo, M., Bánfi, B., & Miller, F. J. (2007) · Circulation · doi:10.1161/circ.116.suppl_16.ii_244-c · Cited by 2
Research works printed but not linked: 1
- Takac, I. et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 286, 13304–13313 (2011). · DOI · Paper page
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
“Although NAD(P)H oxidase as a potential pathogenic mediator of hyperglycemia induced ROS production, there are some major challenges to be overcome when targeting this pathway including redundancy among Nox isoforms (160) and the capacity of pharmacological agents not to interfere with intracellular O2 generation for…”
BackgroundCommensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“…(Miller et al., 2005), has emerges as an important source in vascular oxidative stress in aging, hypertension, hyperlipidemia and diabetes (Faraci et al., 2011), and inhibition or genetic inactivation of this enzyme has been shown to ameliorate the vascular dysfunction (Drummond et al., 2011).”
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Oxidative Stress in Atherosclerosis
Kattoor, A. J., Pothineni, N. V. K., Palagiri, D., & Mehta, J. L. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0678-6 · Cited by 1,266
Metadata
- Authors
- Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G.
- Affiliations
- Monash University (AU)
- Emory University (US)
- Corresponding author
- Drummond, Grant R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2011-06
- Volume
- 10
- Issue
- 6
- Pages
- 453-471
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3361719
- OpenAlex
- W1974997758
- Cited by
- 899
- References
- 237
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 38 · 2023: 35 · 2022: 51 · 2021: 66 · 2020: 69 · 2019: 55 · 2018: 63 · 2017: 77 · 2016: 69 · 2015: 71 · 2014: 83 · 2013: 88 · 2012: 71
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RMIT Research Repository (RMIT University Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (HL38206, R01HL038206, HL095070, HL058863, R37HL038206, HL-092120, R01HL092120, P01HL095070, R01HL058863)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- NADPH oxidase, NOX1, NOX2, oxidative stress, reactive oxygen species, NADPH oxidase inhibitors, p47phox, endothelial dysfunction, vascular inflammation, atherogenesis, arterial remodeling, hypertension, hypercholesterolemia, diabetes mellitus, aging, cardiovascular disease
- MeSH terms
- NADPH Oxidase 1, NADPH Oxidase 2, Animals, Antioxidants, Humans, Membrane Glycoproteins, NADH, NADPH Oxidoreductases, Vascular Diseases, Drug Delivery Systems, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.